Not applicableStudy completedNCT03242083What this trial is testingEvaluate the Quality of Life of Patients With AMDWho this might be right forAge-related Macular Degeneration Centre Hospitalier Universitaire Dijon 28
Large-scale testing (Phase 3)Study completedNCT04264819What this trial is testingStudy of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Novartis Pharmaceuticals 295
Testing effectiveness (Phase 2)Study completedNCT00447954What this trial is testingAn Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular DegenerationWho this might be right forNonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage Neurotech Pharmaceuticals 53
Large-scale testing (Phase 3)Study completedNCT04005352What this trial is testingStudy to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)Who this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 734
Not applicableStudy completedNCT01692938What this trial is testingEvaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLOWho this might be right forAge-Related Macular DegenerationGeographic AtrophyDiabetic Retinopathy+6 more Optos, PLC 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537What this trial is testingA Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Novartis Pharmaceuticals 170
Not applicableStudy completedNCT04723160What this trial is testingComputer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus PhotographWho this might be right forDiabetic RetinopathyRetinal Vein OcclusionRetinal Artery Occlusion+10 more Visionary Intelligence Ltd. 748
Testing effectiveness (Phase 2)Active Not RecruitingNCT05839041What this trial is testingA Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)Who this might be right forGeographic Atrophy of the MaculaMacular Degeneration Aviceda Therapeutics, Inc. 300
Testing effectiveness (Phase 2)Looking for participantsNCT06659549What this trial is testingEfficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDWho this might be right forGeographic Atrophy of the Macula Galimedix Therapeutics Inc 110
Large-scale testing (Phase 3)Study completedNCT04597632What this trial is testingAn Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) StudyWho this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 248
Post-approval studies (Phase 4)Study completedNCT02161575What this trial is testingSafety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMDWho this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 103
Not applicableStudy completedNCT00564902What this trial is testingThe Zeaxanthin and Visual Function StudyWho this might be right forAge Related Macular DegenerationCognition Disorders Chrysantis, Inc. 60
Post-approval studies (Phase 4)Study completedNCT01775124What this trial is testingEfficacy and Safety of Ranibizumab 0.5 mg Administered as Two Alternative Dosing Regimens in Chinese Patients With nAMD (Age Related Macular Degeneration)Who this might be right forNeovascular Age-related Macular Degeneration Novartis Pharmaceuticals 332
Not applicableLooking for participantsNCT06662162What this trial is testingMicrocurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular DegenerationWho this might be right forAge-Related Macular DegenerationAge-related Macular Degeneration (ARMD)Intermediate AMD+1 more i-Lumen Scientific AUS PTY LTD 100
Not applicableLooking for participantsNCT06351657What this trial is testingPersonalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease ProgressionWho this might be right forAge-Related Macular DegenerationGeographic Atrophy Medical University of Vienna 200
Post-approval studies (Phase 4)Study completedNCT04679935What this trial is testingEfficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular DegenerationWho this might be right forAge-related Macular Degeneration Novartis Pharmaceuticals 52
Not applicableStudy completedNCT02051998What this trial is testingDirectional Spread in Geographic AtrophyWho this might be right forNonexudative Age-related Macular Degeneration University Hospital, Bonn 130
Testing effectiveness (Phase 2)Study completedNCT00940407What this trial is testingToronto and Oak Ridge Photobiomodulation Study for Dry Age Related Macular DegenerationWho this might be right forNonexudative Age-related Macular Degeneration Merry, Graham, M.D. 18
Not applicableActive Not RecruitingNCT04676854What this trial is testingRestoration of Central Vision With the PRIMA System in Patients With Atrophic AMDWho this might be right forGeographic Atrophy Science Corporation 38
Not applicableLooking for participantsNCT05706896What this trial is testingAtrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich PlasmaWho this might be right forDry Age-related Macular Degeneration Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36